News

As part of the deal, NeuroVive Asia will get an upfront payment, a conditional milestone payment and royalty on potential future sales in South Korea. The deal will

The acquired business will now be combined with Ergomed’s existing fast growing post-marketing business, PrimeVigilance. The acquisition of Sound Opinion is part of Ergomed’s strategy of strengthening its

Designed using Visterra’s proprietary technology, VIS513 is a humanized monoclonal antibody that is designed to bind and potently neutralize all four serotypes of dengue virus. Preclinical trials of

Unituxin, a monoclonal antibody, is intended for use in children who have responded to an induction treatment with chemotherapy, followed by myeloablative therapy and autologous stem-cell transplantation. Neuroblastoma

Tanner Pharma Group includes three complementary divisions Tanner Clinical Trial Sourcing (TannerCTS), Tanner Global Access Programs (TannerGAP) and Tanner Licensing, Acquisition and Commercialisation (TannerLAC). The new firm’s complementary

The single-dose study is the first stage of the Phase I trial, which the company is currently carrying out for the oral agent of a new molecular entity

The operating property has been occupied by the Company since 2004 pursuant to a lease, and is approximately 25,000 sq. ft. The adjoining property includes a building of

"The grant of this IND marks the achievement of the second important milestone for COTI-2 in 2015 and builds on the Orphan Drug designation received for ovarian cancer

"Asia-Pacific is poised to become the world’s next biopharma powerhouse, not least because of its growing number of emerging companies with promising pipelines," said Senior Vice President Ross